Mediar Therapeutics
0 followers
About Mediar Therapeutics
Mediar Therapeutics is a biotechnology company pursuing unexplored targets to halt and reverse fibrotic activity. The company focuses on the myofibroblast-driven fibrotic micro-environment and aims to neutralize pro-fibrotic mediators with novel antibodies to disable myofibroblasts, slow fibrosis, and enable healing. Its approach centers on developing antibody-based therapies targeting mediators that control fibrosis and extracellular matrix deposition, with clinical trial programs to validate these targets.